These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 26363679)

  • 21. Multiple sclerosis and bipolar disorders: the burden of comorbidity and its consequences on quality of life.
    Carta MG; Moro MF; Lorefice L; Picardi A; Trincas G; Fenu G; Cocco E; Floris F; Bessonov D; Akiskal HS; Marrosu MG
    J Affect Disord; 2014; 167():192-7. PubMed ID: 24995886
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Hospital Anxiety and Depression Scale (HADS) and the 9-item Patient Health Questionnaire (PHQ-9) as screening instruments for depression in patients with cancer.
    Hartung TJ; Friedrich M; Johansen C; Wittchen HU; Faller H; Koch U; Brähler E; Härter M; Keller M; Schulz H; Wegscheider K; Weis J; Mehnert A
    Cancer; 2017 Nov; 123(21):4236-4243. PubMed ID: 28654189
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic accuracy and agreement across three depression assessment measures for Parkinson's disease.
    Thompson AW; Liu H; Hays RD; Katon WJ; Rausch R; Diaz N; Jacob EL; Vassar SD; Vickrey BG
    Parkinsonism Relat Disord; 2011 Jan; 17(1):40-5. PubMed ID: 21084211
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Validating screening tools for depression in stroke and transient ischemic attack patients.
    Prisnie JC; Fiest KM; Coutts SB; Patten SB; Atta CA; Blaikie L; Bulloch AG; Demchuk A; Hill MD; Smith EE; Jetté N
    Int J Psychiatry Med; 2016 Apr; 51(3):262-77. PubMed ID: 27284119
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Screening for depression in cancer patients using the PHQ-9: The accuracy of somatic compared to non-somatic items.
    Grapp M; Terhoeven V; Nikendei C; Friederich HC; Maatouk I
    J Affect Disord; 2019 Jul; 254():74-81. PubMed ID: 31108283
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic validity of the Patient Health Questionnaire-2 (PHQ-2) among Ethiopian adults.
    Gelaye B; Wilson I; Berhane HY; Deyessa N; Bahretibeb Y; Wondimagegn D; Shibre Kelkile T; Berhane Y; Fann JR; Williams MA
    Compr Psychiatry; 2016 Oct; 70():216-21. PubMed ID: 27567282
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validation and internal consistency of Patient Health Questionnaire-9 for major depression in Parkinson's disease.
    Chagas MH; Tumas V; Rodrigues GR; Machado-de-Sousa JP; Filho AS; Hallak JE; Crippa JA
    Age Ageing; 2013 Sep; 42(5):645-9. PubMed ID: 23761457
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detecting recurrent major depressive disorder within primary care rapidly and reliably using short questionnaire measures.
    Thapar A; Hammerton G; Collishaw S; Potter R; Rice F; Harold G; Craddock N; Thapar A; Smith DJ
    Br J Gen Pract; 2014 Jan; 64(618):e31-7. PubMed ID: 24567580
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessing depression symptoms in those with insomnia: an examination of the beck depression inventory second edition (BDI-II).
    Carney CE; Ulmer C; Edinger JD; Krystal AD; Knauss F
    J Psychiatr Res; 2009 Feb; 43(5):576-82. PubMed ID: 18954876
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Borderline personality disorder characteristics in young adults with recurrent mood disorders: a comparison of bipolar and unipolar depression.
    Smith DJ; Muir WJ; Blackwood DH
    J Affect Disord; 2005 Jul; 87(1):17-23. PubMed ID: 15967232
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Validity of brief screening questionnaires to detect depression in primary care in Ethiopia.
    Hanlon C; Medhin G; Selamu M; Breuer E; Worku B; Hailemariam M; Lund C; Prince M; Fekadu A
    J Affect Disord; 2015 Nov; 186():32-9. PubMed ID: 26226431
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lower PHQ-9 cutpoint accurately diagnosed depression in people with long-term conditions attending the Accident and Emergency Department.
    Hyphantis T; Kotsis K; Kroenke K; Paika V; Constantopoulos S; Drosos AA; Carvalho AF; Guthrie E;
    J Affect Disord; 2015 May; 176():155-63. PubMed ID: 25721612
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A clinically useful self-report measure of the DSM-5 mixed features specifier of major depressive disorder.
    Zimmerman M; Chelminski I; Young D; Dalrymple K; Martinez JH
    J Affect Disord; 2014 Oct; 168():357-62. PubMed ID: 25103631
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Validity of the Patient Health Questionnaire-9 in assessing depression following traumatic brain injury.
    Fann JR; Bombardier CH; Dikmen S; Esselman P; Warms CA; Pelzer E; Rau H; Temkin N
    J Head Trauma Rehabil; 2005; 20(6):501-11. PubMed ID: 16304487
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Psychometric properties of the Hamilton Depression Rating Scale in multiple sclerosis.
    Raimo S; Trojano L; Spitaleri D; Petretta V; Grossi D; Santangelo G
    Qual Life Res; 2015 Aug; 24(8):1973-80. PubMed ID: 25669154
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic accuracy, internal consistency, and convergent validity of the Greek version of the patient health questionnaire 9 in diagnosing depression in rheumatologic disorders.
    Hyphantis T; Kotsis K; Voulgari PV; Tsifetaki N; Creed F; Drosos AA
    Arthritis Care Res (Hoboken); 2011 Sep; 63(9):1313-21. PubMed ID: 21618450
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Validation of the Patient Health Questionnaire-9 (PHQ-9) and PHQ-2 in patients with migraine.
    Seo JG; Park SP
    J Headache Pain; 2015; 16():65. PubMed ID: 26174509
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Validation of the Hospital Anxiety and Depression Scale for use with multiple sclerosis patients.
    Honarmand K; Feinstein A
    Mult Scler; 2009 Dec; 15(12):1518-24. PubMed ID: 19965520
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence and correlates of DSM-IV-TR major depressive disorder, self-reported diagnosed depression and current depressive symptoms among adults in Germany.
    Maske UE; Buttery AK; Beesdo-Baum K; Riedel-Heller S; Hapke U; Busch MA
    J Affect Disord; 2016 Jan; 190():167-177. PubMed ID: 26519637
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factor structure and diagnostic efficiency of the BDI-II in treatment-seeking substance users.
    Seignourel PJ; Green C; Schmitz JM
    Drug Alcohol Depend; 2008 Mar; 93(3):271-8. PubMed ID: 18093749
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.